Works matching IS 03618609 AND DT 2023 AND VI 98 AND IP 2

Results: 24
    1

    N‐terminal pro‐brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 2, p. 290, doi. 10.1002/ajh.26805
    By:
    • Graf, Irene;
    • Greiner, Georg;
    • Marculescu, Rodrig;
    • Gleixner, Karoline V.;
    • Herndlhofer, Susanne;
    • Stefanzl, Gabriele;
    • Knoebl, Paul;
    • Jäger, Ulrich;
    • Hauswirth, Alexander;
    • Schwarzinger, Ilse;
    • Thalhammer, Renate;
    • Kundi, Michael;
    • Hoermann, Gregor;
    • Mitterbauer‐Hohendanner, Gerlinde;
    • Valent, Peter;
    • Sperr, Wolfgang R.
    Publication type:
    Article
    2
    3

    The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 2, p. 309, doi. 10.1002/ajh.26792
    By:
    • Cao, Yigeng;
    • Gong, Xiaowen;
    • Feng, Yahui;
    • Wang, Mingyang;
    • Hu, Yu;
    • Liu, Huilan;
    • Liu, Xueou;
    • Qi, Saibing;
    • Ji, Yanping;
    • Liu, Fang;
    • Zhu, Huaiping;
    • Guo, Wenwen;
    • Shen, Qiujin;
    • Zhang, Rongli;
    • Zhao, Ningning;
    • Zhai, Weihua;
    • Song, Xiaoqiang;
    • Chen, Xin;
    • Geng, Liangquan;
    • Chen, Xia
    Publication type:
    Article
    4
    5

    Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 2, p. E35, doi. 10.1002/ajh.26789
    By:
    • Pasvolsky, Oren;
    • Saliba, Rima M.;
    • Ledesma, Celina;
    • Popat, Uday R.;
    • Alousi, Amin;
    • Olson, Amanda;
    • Oran, Betul;
    • Hosing, Chitra;
    • Bashir, Qaiser;
    • Qazilbash, Muzaffar H.;
    • Short, Nicholas J.;
    • Ravandi, Farhad;
    • Champlin, Richard;
    • Shpall, Elizabeth J.;
    • Kebriaei, Partow
    Publication type:
    Article
    6
    7
    8

    Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 2, p. E28, doi. 10.1002/ajh.26786
    By:
    • Mangaonkar, Abhishek A.;
    • Langer, Kimberly J.;
    • Lasho, Terra L.;
    • Finke, Christy;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Shah, Mithun V.;
    • Go, Ronald S.;
    • Bartoo, Gabriel;
    • Kutzke, Jade;
    • McCullough, Kristen B.;
    • Koster, Matthew;
    • Samec, Matthew;
    • Warrington, Kenneth J.;
    • Reichard, Kaaren K.;
    • Olteanu, Horatiu;
    • Riwes, Mary;
    • Patnaik, Mrinal M.;
    • Alkhateeb, Hassan B.
    Publication type:
    Article
    9

    Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 2, p. 264, doi. 10.1002/ajh.26785
    By:
    • Dumontet, Charles;
    • Demangel, Delphine;
    • Galia, Perrine;
    • Karlin, Lionel;
    • Roche, Laurent;
    • Fauvernier, Mathieu;
    • Golfier, Camille;
    • Laude, Marie‐Charlotte;
    • Leleu, Xavier;
    • Rodon, Philippe;
    • Roussel, Murielle;
    • Azaïs, Isabelle;
    • Doyen, Chantal;
    • Slama, Borhane;
    • Manier, Salomon;
    • Decaux, Olivier;
    • Pertesi, Maroulio;
    • Beaumont, Marie;
    • Caillot, Denis;
    • Boyle, Eileen M.
    Publication type:
    Article
    10

    Outcomes of patients with limited‐stage plasmablastic lymphoma: A multi‐institutional retrospective study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 2, p. 300, doi. 10.1002/ajh.26784
    By:
    • Hess, Brian T.;
    • Giri, Anshu;
    • Park, Yeonhee;
    • Patel, Krina K.;
    • Link, Brian K.;
    • Nowakowski, Grzegorz S.;
    • Maliske, Seth M.;
    • Fortin, Sonia;
    • Chavez, Julio C.;
    • Saeed, Hayder;
    • Hill, Brian T.;
    • Mejia Garcia, Alex V.;
    • Maddocks, Kami J.;
    • Hanel, Walter;
    • Wagner‐Johnston, Nina D.;
    • Messmer, Marcus R.;
    • Kahl, Brad S.;
    • Watkins, Marcus;
    • Alderuccio, Juan Pablo;
    • Lossos, Izidore S.
    Publication type:
    Article
    11
    12

    Post‐transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA‐mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 2, p. E41, doi. 10.1002/ajh.26782
    By:
    • Wieczorek, Michele;
    • Labopin, Myriam;
    • Castagna, Luca;
    • Brissot, Eolia;
    • Socié, Gerard;
    • Raiola, Anna Maria;
    • Angelucci, Emanuele;
    • Rodríguez, Arancha Bermúdez;
    • Yakoub‐Agha, Ibrahim;
    • Aljurf, Mahmoud;
    • Crawley, Charles;
    • Mear, Jean Baptiste;
    • Musso, Maurizio;
    • Fanin, Renato;
    • Avenoso, Daniele;
    • Turlure, Pascal;
    • Tecchio, Cristina;
    • Sanz, Jaime;
    • Ciceri, Fabio;
    • Nagler, Arnon
    Publication type:
    Article
    13
    14
    15

    Efficacy of front‐line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real‐World" study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 2, p. E24, doi. 10.1002/ajh.26779
    By:
    • Levi, Shai;
    • Bronstein, Yotam;
    • Goldschmidt, Neta;
    • Morabito, Fortunato;
    • Ziv‐Baran, Tomer;
    • Del Poeta, Giovanni;
    • Bairey, Osnat;
    • Del Principe, Maria Ilaria;
    • Fineman, Riva;
    • Mauro, Francesca Romana;
    • Gutwein, Odit;
    • Reda, Gianluigi;
    • Ruchlemer, Rosa;
    • Sportoletti, Paolo;
    • Laurenti, Luca;
    • Shvidel, Lev;
    • Coscia, Marta;
    • Tadmor, Tamar;
    • Varettoni, Marzia;
    • Aviv, Ariel
    Publication type:
    Article
    16
    17
    18

    A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 2, p. 272, doi. 10.1002/ajh.26771
    By:
    • Zeidan, Amer M.;
    • Borate, Uma;
    • Pollyea, Daniel A.;
    • Brunner, Andrew M.;
    • Roncolato, Fernando;
    • Garcia, Jacqueline S.;
    • Filshie, Robin;
    • Odenike, Olatoyosi;
    • Watson, Anne Marie;
    • Krishnadasan, Ravitharan;
    • Bajel, Ashish;
    • Naqvi, Kiran;
    • Zha, Jiuhong;
    • Cheng, Wei‐Han;
    • Zhou, Ying;
    • Hoffman, David;
    • Harb, Jason G.;
    • Potluri, Jalaja;
    • Garcia‐Manero, Guillermo
    Publication type:
    Article
    19

    Health‐related quality of life in reduced‐intensity hematopoietic cell transplantation based on donor availability in patients aged 50–75 with advanced myelodysplastic syndrome: BMT CTN 1102.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 2, p. 229, doi. 10.1002/ajh.26768
    By:
    • Cusatis, Rachel;
    • Martens, Michael J.;
    • Nakamura, Ryotaro;
    • Cutler, Corey S.;
    • Saber, Wael;
    • Lee, Stephanie J.;
    • Logan, Brent R.;
    • Shaw, Bronwen E.;
    • Gregory, Alyssa;
    • D'Souza, Anita;
    • Hamilton, Betty K.;
    • Horowitz, Mary M.;
    • Flynn, Kathryn E.
    Publication type:
    Article
    20
    21
    22

    Issue Information.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 2, p. 223, doi. 10.1002/ajh.26605
    Publication type:
    Article
    23
    24